Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $10.11 and traded as low as $9.13. Bavarian Nordic A/S shares last traded at $9.25, with a volume of 5,030 shares.
Bavarian Nordic A/S Stock Up 2.7 %
The stock has a fifty day moving average price of $9.00 and a two-hundred day moving average price of $10.11. The company has a market capitalization of $2.19 billion, a price-to-earnings ratio of 13.41 and a beta of 1.65.
About Bavarian Nordic A/S
(
Get Free Report)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Stories
Before you consider Bavarian Nordic A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic A/S wasn't on the list.
While Bavarian Nordic A/S currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
